Letrozole 1.25mg (#540018)
$45.00 Original price was: $45.00.$35.00Current price is: $35.00.
Letrozole 1.25mg — a non-steroidal aromatase inhibitor, supplied as a research and reference compound. For laboratory research use only. Not for human consumption.
What is Letrozole?
Letrozole is a non-steroidal aromatase inhibitor — a prescription medicine that blocks the aromatase enzyme responsible for converting androgens into estrogens. It is a standard therapy in postmenopausal breast cancer and also appears in fertility-medicine literature. Its pharmacology is documented in oncology and endocrinology research. This listing presents letrozole as a research and reference compound; it is not presented as a hormone-“restoration” or protocol product, and no personal-use guidance is provided.
Specifications
| Field | Value |
|---|---|
| Compound | Letrozole |
| Class | Aromatase inhibitor (non-steroidal, triazole) |
| Molecular formula | C17H11N5 |
| Molecular weight | 285.31 g/mol |
| CAS number | 112809-51-5 |
| PubChem CID | 3902 |
| Presentation | 1.25mg tablets, as labelled |
Research context
Letrozole is studied in oncology (estrogen suppression in hormone-receptor-positive breast cancer), reproductive medicine, and aromatase-pathway biochemistry. Aromatase inhibitors are prohibited in sport (WADA). The clinical literature administers it under physician direction for diagnosed conditions; no use schedules are reproduced here.
For laboratory research use only. Not for human consumption.
Only logged in customers who have purchased this product may leave a review.

Reviews
There are no reviews yet.